| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |